Telix Pharmaceuticals (TLX1N) Q2 2023 Earnings Report
MX:TLX1N Q2 2023 EPS Results
- Actual EPS
- -MXN 0.54
- Consensus EPS
- MXN 0.69
- Beat/Miss
- Missed by -MXN 1.23
- One Year Ago EPS
- -MXN 2.99
MX:TLX1N Q2 2023 Revenue Results
- Actual Revenue
- MXN 2.91B
- Expected Revenue
- MXN 1.53B
- Beat/Miss
- Beat by +MXN 1.38B
- YoY Revenue Growth
- +818.34%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/23/2023
- Time
- Before Open
- Conference Call
- Wednesday, August 23, 2023
MX:TLX1N Upcoming Earnings
Telix Pharmaceuticals's next earnings date is estimated for February 19, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
MX:TLX1N Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:TLX1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 19, 2027 | 2026 (Q4) | 1.12- | -0.22 | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | 0.373.17 | 0.19 | 1600.00% (+2.99) | |
| Feb 19, 2026 | 2025 (Q4) | 0.75-0.22 | 0.71 | -131.58% (-0.93) | |
| Aug 20, 2025 | 2025 (Q2) | 3.430.19 | 1.14 | -83.61% (-0.95) | |
| Feb 20, 2025 | 2024 (Q4) | 0.690.71 | 0.69 | 2.70% (+0.02) | |
| Aug 22, 2024 | 2024 (Q2) | 1.831.14 | -0.54 | 310.34% (+1.68) | |
| Feb 22, 2024 | 2023 (Q4) | 0.910.69 | -0.3 | 331.25% (+0.99) | |
| Aug 23, 2023 | 2023 (Q2) | 0.69-0.54 | -2.99 | 81.88% (+2.44) | |
| Apr 17, 2023 | 2023 (Q1) | ―- | -2.23 | ― | |
| Feb 27, 2023 | 2022 (Q4) | -0.91-0.30 | -2.24 | 86.67% (+1.94) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
